| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_58987629b3d8dbcc4b6120918be03177
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c90c49b7ba36e7dcb625797ab2b01906
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e7e9ce91d4ac2a3e7491a78bb09ec2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ced57a347b588ef4bdf841fb5338e3f4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 |
| filingDate |
1998-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90c0f695343067a6be3de2e81aed5137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3957399e1a166c4743c58e361be13dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99b7d1d33c45bd347571151a715267e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dd1c21e8c6069c0985c0345b9c68c1d |
| publicationDate |
1999-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
LT-4441-B |
| titleOfInvention |
ANTIGLIUCOSCYCORIC MEDICINAL PRODUCT |
| abstract |
The invention is related to medicine and veterinary fields, in particular to nonsteroidal antiglucocorticoids. An aim of the invention is the establishment of a new class of drugs with low toxicity and high activity in regulation of sensitivity of mammalian cells to the glucocorticoid hormones. There is a naval application of an insect pheromone with long-chain aliphatic nonsteroidal structure or its synthetic analog or derivative that is unsaturated aliphatic alcohol, aldehyde or ester, for specific inhibition of glucocorticoid hormone influence on mammalian cells. The aliphatic carbon chain length of these pheromones varies from 10 to 21 carbon atoms. There is also a possibility of combining application of two or more pheromones and/or their synthetic analogs and derivatives for enhancement of therapeutic activity, selection being made on the basis of different hydrophobic properties proportional to the aliphatic carbon chain length. Difference in lengths of these chains must be no loss than five carbon atoms. Example of preparation of the pharmaceutical forms and results of comparative experiments that show their high activity are disclosed. |
| priorityDate |
1996-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |